Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment:prospective study

Autor: Isoniemi, H. (H.), Uutela, A. (A.), Nordin, A. (A.), Lantto, E. (E.), Kellokumpu, I. (I.), Ovissi, A. (A.), Kosunen, J. (J.), Kallio, R. (R.), Soveri, L. M. (L. M.), Salminen, T. (T.), Ålgars, A. (A.), Lamminmäki, A. (A.), Halonen, P. (P.), Ristamäki, R. (R.), Räsänen, J. (J.), Karjula, H. (H.), Vaalavuo, Y. (Y.), Lavonius, M. (M.), Osterlund, P. (P.)

Background: Metastasectomy is probably underused in metastatic colorectal cancer. The aim of this study was to investigate the effect of centralized repeated assessment on resectability rate of liver metastases. Methods: The prospective RAXO study wa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2423::fa96dd46b9d000bc712b5bb845703956
http://urn.fi/urn:nbn:fi-fe2021100850414

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prognostic impact of CD73 expression and its relationship to PD-L1 in patients with radically treated pancreatic cancer.

Autor: Tahkola K; Department of Surgery, Central Finland Central Hospital, Keskussairaalantie 19, 40620, Jyväskylä, Finland. kyosti.tahkola@gmail.com.; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. kyosti.tahkola@gmail.com., Ahtiainen M; Department of Education and Research, Central Finland Central Hospital, Jyväskylä, Finland., Kellokumpu I; Department of Surgery, Central Finland Central Hospital, Keskussairaalantie 19, 40620, Jyväskylä, Finland., Mecklin JP; Department of Surgery, Central Finland Central Hospital, Keskussairaalantie 19, 40620, Jyväskylä, Finland.; Sport &Health Sciences, University of Jyväskylä, Jyväskylä, Finland., Laukkarinen J; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland., Laakkonen J; MediCity Research Laboratory and Institute of Biomedicine, University of Turku, Turku, Finland., Kenessey I; MediCity Research Laboratory and Institute of Biomedicine, University of Turku, Turku, Finland., Jalkanen S; MediCity Research Laboratory and Institute of Biomedicine, University of Turku, Turku, Finland., Salmi M; MediCity Research Laboratory and Institute of Biomedicine, University of Turku, Turku, Finland., Böhm J; Department of Pathology, Central Finland Central Hospital, Jyväskylä, Finland.

Publikováno v: Virchows Archiv : an international journal of pathology [Virchows Arch] 2021 Feb; Vol. 478 (2), pp. 209-217. Date of Electronic Publication: 2020 Jul 16.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Immunoscore in Mismatch Repair-Proficient and -Deficient Colon Cancer

Autor: Wirta, E.-V. (Erkki-Ville), Seppälä, T. (Toni), Friman, M. (Marjukka), Väyrynen, J. (Juha), Ahtiainen, M. (Maarit), Kautiainen, H. (Hannu), Kuopio, T. (Teijo), Kellokumpu, I. (Ilmo), Mecklin, J.-P. (Jukka-Pekka), Böhm, J. (Jan)

The aim of this study was to investigate immune response and its prognostic significance in colon carcinomas using the previously described Immunoscore (IS). A population-based series of 779 colorectal cancers, operated on between 2000 and 2010, were

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8c85496fc7967c278193dd0253114396
http://urn.fi/URN:NBN:fi:jyu-201708043413